447 related articles for article (PubMed ID: 10468968)
41. Histopathological features of atrophic thyroiditis with blocking type-TSH binding inhibitor immunoglobulins.
Sugenoya A; Itoh N; Kasuga Y; Kobayashi S; Ohhashi T; Nagai N; Iida F
Endocr J; 1995 Apr; 42(2):277-81. PubMed ID: 7627273
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Follow-Up and Outcomes of Autoimmune Thyroiditis in Childhood.
Admoni O; Rath S; Almagor T; Elias-Assad G; Tenenbaum-Rakover Y
Front Endocrinol (Lausanne); 2020; 11():309. PubMed ID: 32582023
[No Abstract] [Full Text] [Related]
43. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Brokken LJ; Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
[TBL] [Abstract][Full Text] [Related]
44. Thyroid status and the levels of thyroid auto-antibodies in the sera of hyperthyroid and goitrous subjects.
Chinyanga EA; Benni A; Siziya S
Cent Afr J Med; 2000 Sep; 46(9):251-5. PubMed ID: 11320772
[TBL] [Abstract][Full Text] [Related]
45. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
[TBL] [Abstract][Full Text] [Related]
46. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
Kawai K; Tamai H; Matsubayashi S; Mukuta T; Morita T; Kubo C; Kuma K
Clin Endocrinol (Oxf); 1995 Nov; 43(5):551-6. PubMed ID: 8548939
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
48. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
Connors MH; Styne DM
Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
[TBL] [Abstract][Full Text] [Related]
49. Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies.
Kasagi K; Hatabu H; Miyamoto S; Takeuchi R; Misaki T; Sakahara H; Iida Y; Konishi J
Eur J Nucl Med; 1994 Sep; 21(9):962-7. PubMed ID: 7995290
[TBL] [Abstract][Full Text] [Related]
50. A strong association between thyrotropin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans.
Cho BY; Chung JH; Shong YK; Chang YB; Han H; Lee JB; Lee HK; Koh CS
J Clin Endocrinol Metab; 1993 Sep; 77(3):611-5. PubMed ID: 8103769
[TBL] [Abstract][Full Text] [Related]
51. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine.
Traub-Weidinger T; Graf S; Beheshti M; Ofluoglu S; Zettinig G; Khorsand A; Nekolla SG; Kletter K; Dudczak R; Pirich C
Thyroid; 2012 Mar; 22(3):245-51. PubMed ID: 22233129
[TBL] [Abstract][Full Text] [Related]
52. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
53. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.
Costagliola S; Many MC; Stalmans-Falys M; Tonacchera M; Vassart G; Ludgate M
Endocrinology; 1994 Nov; 135(5):2150-9. PubMed ID: 7956939
[TBL] [Abstract][Full Text] [Related]
54. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
[TBL] [Abstract][Full Text] [Related]
55. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
56. Relationship of antibodies to thyrotropin receptors and to thyroid ultrasonographic volume in euthyroid and hypothyroid patients with autoimmune thyroiditis.
Rieu M; Portos C; Lissak B; Laplanche S; Sambor B; Berrod JL; Fombeur JP
J Clin Endocrinol Metab; 1996 Feb; 81(2):641-5. PubMed ID: 8636282
[TBL] [Abstract][Full Text] [Related]
57. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
58. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.
Kraiem Z; Lahat N; Glaser B; Baron E; Sadeh O; Sheinfeld M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):409-21. PubMed ID: 2830061
[TBL] [Abstract][Full Text] [Related]
59. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit?
Padberg S; Heller K; Usadel KH; Schumm-Draeger PM
Thyroid; 2001 Mar; 11(3):249-55. PubMed ID: 11327616
[TBL] [Abstract][Full Text] [Related]
60. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.
de Bruin TW; van der Heide D; Querido A; Krol MC
Clin Endocrinol (Oxf); 1984 Feb; 20(2):143-51. PubMed ID: 6325045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
